[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369769-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-369769-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","prognostic-and-therapeutic-relevance-of-il2rg-related-lncrnas-in-clear-cell-renal-cell-carcinoma","Prognostic and therapeutic relevance of IL2RG-related LncRNAs in clear cell renal cell carcinoma","","Interleukin-2 Receptor Subunit Gamma (IL2RG) is examined for its prognostic and therapeutic relevance in clear cell renal cell carcinoma (ccRCC), focusing on IL2RG-related long non-coding RNAs (IRLs). Gene expression and clinical cohorts are integrated from TCGA and GEO to build a  LASSO-derived IRL signature. Diagnostic utility is validated, while survival performance is assessed using Kaplan–Meier and ROC analyses, complemented by calibration and decision curve evaluation of a nomogram. Immune biology and tumor microenvironment differences are profiled by GSEA, ssGSEA, CIBERSORT, and TISCH2. The model associates high-risk status with immune-related pathway enrichment and predicts greater sensitivity to sunitinib and temsirolimus. Experimental validation uses qRT-PCR and IHC, supporting IL2RG and the 6-IRLs model as ccRCC biomarkers to guide therapy.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/prognostic-and-therapeutic-relevance-of-il2rg-related-lncrnas-in-clear-cell-renal-cell-carcinoma/369769/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/prognostic-and-therapeutic-relevance-of-il2rg-related-lncrnas-in-clear-cell-renal-cell-carcinoma/369769.png","ImageObject",300,407,{"name":42,"@type":43},"Mabel","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-13","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What question does the study investigate about IL2RG in ccRCC?","Question",{"text":63,"@type":64},"The study investigates whether IL2RG expression and IL2RG-related lncRNAs (IRLs) have prognostic and therapeutic relevance in clear cell renal cell carcinoma.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is the IL2RG-related lncRNA signature built and validated?",{"text":68,"@type":64},"An IRL signature is constructed using LASSO regression on TCGA and GEO gene expression and clinical data, then validated for diagnostic value and survival prediction using ROC and Kaplan–Meier analyses.",{"name":70,"@type":61,"acceptedAnswer":71},"Which methods are used to analyze immune function and the tumor microenvironment by risk group?",{"text":72,"@type":64},"Immune function and infiltration are evaluated using GSEA, ssGSEA, CIBERSORT, and the TISCH2 database, comparing immune-related features across different risk groups.",{"name":74,"@type":61,"acceptedAnswer":75},"What treatment sensitivity does the risk model suggest for ccRCC patients?",{"text":76,"@type":64},"Drug sensitivity analysis predicts that high-risk patients are more responsive to sunitinib and temsirolimus.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},369769,1790210903,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,124,127,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":120,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":122,"slug":123},9,"Religion & Spirituality",20,"religion-spirituality",{"id":122,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":122,"slug":126},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":122,"language":143,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":12,"update_tm":147,"read_time":108,"preview_page_count":33,"preview_urls":148},7971474920318,"https://ap-avatar.wpscdn.com/avatar/74000ee537e6b0ca360?x-image-process=image/resize,m_fixed,w_180,h_180&k=1788430171632181674","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nPrognostic and therapeutic relevance of IL2RG-related LncRNAs in clear cell renal cell carcinoma  \nWeijing Hu1,6, BoWu2,6, Yongquan Chen3, Xiaoling Guo4, Xiaosong Wang1 & Dongwen Wang1,5􀀍  \nInterleukin-2 Receptor Subunit Gamma (IL2RG) has been implicated in various cancers, but its role in clear cell renal cell carcinoma (ccRCC) remains unclear. This study aimed to explore IL2RG expression, its relationship with IL2RG-related lncRNAs (IRLs) . Gene expression and clinical data for ccRCC were obtained from The Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus(GEO) database. The IRL signature was constructed using Least Absolute Shrinkage and Selection Operator (LASSO) regression analysis. Clinical data validated the diagnostic value of the signature. The prognostic value of the signal was assessed using Kaplan-Meier analysis and Receiver Operating Characteristic (ROC) curves. The prognostic value of the nomogram was further evaluated through calibration curves, ROC curves, and Decision Curve Analysis (DCA). Gene set enrichment analysis (GSEA), single-sample GSEA (ssGSEA), CIBERSORT algorithms, and TISCH2 database were applied to analyze immune function and immune cell infiltration in different risk groups. Clinical treatment differences among populations with varying risks and susceptibilities were predicted using R packages. The expression of IL2RG and key lncRNAs was validated by quantitative real-time polymerase chain reaction (qRT-PCR) and immunohistochemistry (IHC). IL2RG was significantly upregulated in ccRCC tissues and correlated with advanced clinical stages (p \u003C 0.001) . High IL2RG expression was linked to worse overall survival (OS), disease-specific survival (DSS), and progression-free interval (PFI) (p \u003C 0.05). A 6-IRLs signature was identified, and the resulting model accurately predicted survival outcomes. Immune-related pathways were enriched in high-risk patients, and drug sensitivity analysis indicated that high-risk patients were more responsive to sunitinib and temsirolimus. IL2RG and its related 6-IRLs are potential biomarkers for ccRCC progression. The 6-IRLs model provides a robust tool for predicting prognosis and guiding therapeutic decisions.  \nKeywords Clear cell renal cell carcinoma (ccRCC), Interleukin-2 Receptor Subunit Gamma (IL2RG), Long non-coding RNAs (lncRNAs), Biomarkers, Immune response, Tumor microenvironment (TME)  \nRenal cell carcinoma (RCC) is a highly malignant tumor originating from the renal tubular epithelium system1. In developed countries, the annual incidence of RCC continues to rise2. Clear cell renal cell carcinoma (ccRCC) is the most prevalent subtype, accounting for approximately 70–80% of all renal cancer cases3. It is notorious for its aggressive behavior and high metastatic potential, making treatment and management particularly challenging4. Clinically, ccRCC is often diagnosed at an advanced stage due to the lack of overt symptoms in its early phases. Treatment options for ccRCC include surgical interventions such as radical nephrectomy5. However, advanced or metastatic ccRCC often precludes surgical options, necessitating targeted therapies, immunotherapies, or a combination of both. Yet, the tumor microenvironment is characterized by significant immune suppression, leading to poor prognoses6. Therefore, unraveling the complex molecular mechanisms underlying ccRCC,  \n1Shanxi Medical University, Taiyuan 030001, Shanxi, China. 2Department of Urology, First Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi, China. 3Department of Urology, Shanxi Coal Center Hospital, Taiyuan 030001, Shanxi, China. 4Geriatrics Department, Xi’an Central Hospital, Xi’an 710003, China. 5National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen 518116, Guangdong, China. 6Wei","cbCaipOiBdKBt2D7","https://ap.wps.com/l/cbCaipOiBdKBt2D7","pdf",5244571,"English","# Prognostic and therapeutic relevance of IL2RG-related LncRNAs in ccRCC\n## Data sources and IRL signature construction\n## Diagnostic, prognostic, and nomogram evaluation\n## Immune profiling, risk stratification, and treatment sensitivity prediction\n## Experimental validation of IL2RG and key lncRNAs","[{\"question\":\"What question does the study investigate about IL2RG in ccRCC?\",\"answer\":\"The study investigates whether IL2RG expression and IL2RG-related lncRNAs (IRLs) have prognostic and therapeutic relevance in clear cell renal cell carcinoma.\"},{\"question\":\"How is the IL2RG-related lncRNA signature built and validated?\",\"answer\":\"An IRL signature is constructed using LASSO regression on TCGA and GEO gene expression and clinical data, then validated for diagnostic value and survival prediction using ROC and Kaplan–Meier analyses.\"},{\"question\":\"Which methods are used to analyze immune function and the tumor microenvironment by risk group?\",\"answer\":\"Immune function and infiltration are evaluated using GSEA, ssGSEA, CIBERSORT, and the TISCH2 database, comparing immune-related features across different risk groups.\"},{\"question\":\"What treatment sensitivity does the risk model suggest for ccRCC patients?\",\"answer\":\"Drug sensitivity analysis predicts that high-risk patients are more responsive to sunitinib and temsirolimus.\"}]","Prognostic and therapeutic relevance of IL2RG-related LncRNAs in clear cell renal cell carcinoma | PDF",1790184455,[149,153,157,161],{"page_no":22,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1fbaa6c7abbf1da492268b143a1a6cf6.webp",983,1291,{"page_no":26,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a15c028a2514ae6c94ce48a85cf4f2b2.webp",982,1290,{"page_no":30,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8115eaad75ac912f40563369da3900b8.webp",981,1289,{"page_no":33,"url":162,"width":163,"height":164},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e756af796bf3ed060268811bfe3f92f1.webp",980,1287]